Jennifer GoodÂ
Board of Directors
sensient
Liechtenstein
Biography
Ms. Good, a director of the Company since September 2017, is the co-founder, President, and Chief Executive Officer at Trevi Therapeutics, a late-stage clinical development company. Prior to founding Trevi, she served as President and Chief Executive Officer and as Chief Financial Officer at Penwest Pharmaceuticals, where she successfully led the transition of Penwest Pharmaceuticals from a development stage company to a profitable commercial stage company generating annual revenues in excess of $50 million and negotiating the sale of the Company to its major partner.
Research Interest
Business Developmen
